Publications by the researcher in collaboration with Paolo Prandoni (27)

2026

  1. Association of Obesity With Mortality and Bleeding in Cancer-Associated Venous Thromboembolism

    Mayo Clinic Proceedings, Vol. 101, Núm. 10, pp. 1687-1699

  2. Characteristics and outcomes of acute pulmonary embolism among patients with polyvascular, single-vascular or no atherosclerotic disease: insights from RIETE

    Clinical Research in Cardiology, Vol. 115, Núm. 3, pp. 472-483

  3. Distinct Predictors of Post-thrombotic Symptoms, Signs, and Ulcers after a First Episode Deep Vein Thrombosis: A RIETE Registry Study

    European Journal of Vascular and Endovascular Surgery

  4. Outcomes and predictors of complications after distal deep vein thrombosis: a prospective analysis of 8488 patients

    Journal of Thrombosis and Haemostasis, Vol. 24, Núm. 8, pp. 2865-2875

  5. Outcomes in venous thromboembolism with retained vs removed inferior vena cava filters: an analysis from the Registro Informatizado de Enfermedad TromboEmbólica

    Research and Practice in Thrombosis and Haemostasis, Vol. 10, Núm. 4

  6. Oxygen saturation and mortality for acute pulmonary embolism: multinational retrospective cohort study

    eClinicalMedicine, Vol. 94

  7. Pleural effusion as a mortality predictor for acute pulmonary embolism

    Research and Practice in Thrombosis and Haemostasis, Vol. 10, Núm. 5

  8. Upper Extremity Deep Vein Thrombosis in Cancer Patients

    JACC: CardioOncology, Vol. 8, Núm. 3, pp. 266-278

2025

  1. Acute pulmonary embolism: A multimarker calculator to predict short-term outcomes

    European Heart Journal, Vol. 46, Núm. 45, pp. 4921-4929

  2. Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry

    American Journal of Hematology

  3. Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE

    Research and Practice in Thrombosis and Haemostasis, Vol. 9, Núm. 8

  4. External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the Registro Informatizado Enfermedad TromboEmbὀlica Registry

    Journal of Thrombosis and Haemostasis, Vol. 23, Núm. 12, pp. 3909-3919

  5. Venous thromboembolism in patients aged ≥90 years: Trends in clinical features, treatment, and outcomes—RIETE registry

    Journal of the American Geriatrics Society, Vol. 73, Núm. 4, pp. 1219-1226

2024

  1. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

2023

  1. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

    Thrombosis Update, Vol. 13

  2. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7

  3. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981

  4. The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research

  5. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823

2022

  1. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Chest, Vol. 161, Núm. 2, pp. 524-534